Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07870330

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children

Conditions: Seasonal Influenza

Sex: All
Ages: 9 Years – 17 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 96
Sponsor: ModernaTX, Inc.

Location: Paradigm Clinical Research Centers, LLC Modesto California

Summary

The purpose of this study is to evaluate safety, reactogenicity, and immunogenicity of mRNA-1010 in healthy children (9 to \

Eligibility Criteria

Inclusion Criteria: * 9 to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07870330). StuddyBuddy aggregates publicly available trial information.